The Neuroinflammation Perspective of Depression: Reuniting the Outstanding Mechanisms of the Pathophysiology
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Neuroinflammation Perspective of Depression: Reuniting the Outstanding Mechanisms of the Pathophysiology
Authors
Keywords
-
Journal
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
Volume 26, Issue 2, Pages 196-206
Publisher
Informa UK Limited
Online
2016-05-30
DOI
10.5455/bcp.20160520092044
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel approaches for the management of depressive disorders
- (2016) Manuella P. Kaster et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Role of calcium, glutamate and NMDA in major depression and therapeutic application
- (2016) Lorenz Deutschenbaur et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Inflammation and clinical response to treatment in depression: A meta-analysis
- (2015) R. Strawbridge et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders
- (2015) Mark J. Millan et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Depression and Its Comorbid Conditions More Serious in Women than in Men in the United States
- (2015) Woo Kyoung Kim et al. JOURNAL OF WOMENS HEALTH
- Icariin exerts an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal neuroinflammation
- (2015) B. Liu et al. NEUROSCIENCE
- The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders
- (2015) G.Z. Réus et al. NEUROSCIENCE
- Ketamine ameliorates depressive-like behaviors and immune alterations in adult rats following maternal deprivation
- (2015) Gislaine Z. Réus et al. NEUROSCIENCE LETTERS
- New hypothesis and treatment targets of depression: an integrated view of key findings
- (2015) Shangli Cai et al. Neuroscience Bulletin
- Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review
- (2015) Nicolas D. Iadarola et al. Therapeutic Advances in Chronic Disease
- Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation
- (2014) Carolina Hoyo-Becerra et al. BRAIN BEHAVIOR AND IMMUNITY
- Microglial NLRP3 inflammasome activation mediates IL-1β-related inflammation in prefrontal cortex of depressive rats
- (2014) Ying Pan et al. BRAIN BEHAVIOR AND IMMUNITY
- NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder
- (2013) Elísabet Alcocer-Gómez et al. BRAIN BEHAVIOR AND IMMUNITY
- Involvement of Inflammasome Activation in Lipopolysaccharide-induced Mice Depressive-like Behaviors
- (2013) Yi Zhang et al. CNS Neuroscience & Therapeutics
- GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine
- (2013) Rong-Jian Liu et al. NEUROPSYCHOPHARMACOLOGY
- NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice
- (2013) Adam K Walker et al. NEUROPSYCHOPHARMACOLOGY
- Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: A meta-analysis
- (2013) Kyoung-Sae Na et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The Role of Eukaryotic Elongation Factor 2 Kinase in Rapid Antidepressant Action of Ketamine
- (2012) Lisa M. Monteggia et al. BIOLOGICAL PSYCHIATRY
- The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses
- (2012) Masaaki Iwata et al. BRAIN BEHAVIOR AND IMMUNITY
- Chronic Stress Induced Remodeling of the Prefrontal Cortex: Structural Re-Organization of Microglia and the Inhibitory Effect of Minocycline
- (2012) M. Hinwood et al. CEREBRAL CORTEX
- Targeting the Glutamatergic System to Treat Major Depressive Disorder
- (2012) Daniel C. Mathews et al. DRUGS
- A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
- (2012) Charles L. Raison et al. JAMA Psychiatry
- Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice
- (2011) E Beurel et al. MOLECULAR PSYCHIATRY
- The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
- (2011) Jonas Hannestad et al. NEUROPSYCHOPHARMACOLOGY
- Depression and Hypothalamic-Pituitary-Adrenal Activation: A Quantitative Summary of Four Decades of Research
- (2011) Cinnamon Stetler et al. PSYCHOSOMATIC MEDICINE
- Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood–brain barrier integrity
- (2011) Johann Steiner et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions
- (2010) Ross J. Tynan et al. BRAIN BEHAVIOR AND IMMUNITY
- Role of the mTOR signaling pathway in the rapid antidepressant action of ketamine
- (2010) Kenji Hashimoto Expert Review of Neurotherapeutics
- The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
- (2010) M. Maes et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Cytokines and Glucocorticoid Receptor Signaling
- (2009) Thaddeus W. W. Pace et al. Annals of the New York Academy of Sciences
- Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
- (2009) Andrew H. Miller et al. BIOLOGICAL PSYCHIATRY
- A Meta-Analysis of Cytokines in Major Depression
- (2009) Yekta Dowlati et al. BIOLOGICAL PSYCHIATRY
- Imbalance between Pro- and Anti-inflammatory Cytokines, and between Th1 and Th2 Cytokines in Depressed Patients: The Effect of Electroacupuncture or Fluoxetine Treatment
- (2009) C. Song et al. PHARMACOPSYCHIATRY
- Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
- (2008) J C O'Connor et al. MOLECULAR PSYCHIATRY
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
- (2008) Gerard Sanacora et al. NATURE REVIEWS DRUG DISCOVERY
- Ketamine inhibits tumor necrosis factor-α and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation
- (2007) Gone-Jhe Wu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide
- (2006) Johann Steiner et al. JOURNAL OF PSYCHIATRIC RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started